AU4818297A - Cytokine enhanced immunotherapy for brain tumors - Google Patents
Cytokine enhanced immunotherapy for brain tumorsInfo
- Publication number
- AU4818297A AU4818297A AU48182/97A AU4818297A AU4818297A AU 4818297 A AU4818297 A AU 4818297A AU 48182/97 A AU48182/97 A AU 48182/97A AU 4818297 A AU4818297 A AU 4818297A AU 4818297 A AU4818297 A AU 4818297A
- Authority
- AU
- Australia
- Prior art keywords
- brain tumors
- cytokine
- enhanced immunotherapy
- immunotherapy
- cytokine enhanced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000003174 Brain Neoplasms Diseases 0.000 title 1
- 102000004127 Cytokines Human genes 0.000 title 1
- 108090000695 Cytokines Proteins 0.000 title 1
- 238000009169 immunotherapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73159796A | 1996-10-16 | 1996-10-16 | |
US08731597 | 1996-10-16 | ||
PCT/US1997/018455 WO1998016246A1 (en) | 1996-10-16 | 1997-10-15 | Cytokine enhanced immunotherapy for brain tumors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4818297A true AU4818297A (en) | 1998-05-11 |
Family
ID=24940192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU48182/97A Abandoned AU4818297A (en) | 1996-10-16 | 1997-10-15 | Cytokine enhanced immunotherapy for brain tumors |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0930892A1 (en) |
JP (1) | JP2001502331A (en) |
AU (1) | AU4818297A (en) |
CA (1) | CA2267977A1 (en) |
WO (1) | WO1998016246A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09506866A (en) * | 1993-12-14 | 1997-07-08 | ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン | Controlled release of pharmaceutically active substances for immunotherapy |
US6277368B1 (en) | 1996-07-25 | 2001-08-21 | The Regents Of The University Of California | Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine |
DE69939821D1 (en) * | 1998-04-02 | 2008-12-11 | Univ California | COMPOSITIONS FOR INCREASING THE NUMBER OF ANY PRESENTING CELLS AND THE ANTITUMOROUS ANSWER IN HUMAN PATIENTS |
AU2457701A (en) * | 1999-12-28 | 2001-07-09 | Brown University Research Foundation | Methods and products for tumor immunotherapy using cytokines |
RU2272644C2 (en) * | 2000-06-29 | 2006-03-27 | Мерк Патент Гмбх | Enhancement of immune response wherein fused protein antibody-cytokine is mediator by combined treatment with agents increasing immunocytokine absorption |
US6911204B2 (en) | 2000-08-11 | 2005-06-28 | Favrille, Inc. | Method and composition for altering a B cell mediated pathology |
CA2479528A1 (en) * | 2002-03-25 | 2003-10-02 | Technologies Biolactis Inc. | Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof |
EP1374893A1 (en) | 2002-06-17 | 2004-01-02 | NovImmune S.A. | Vaccination with immuno-isolated cells producing an immunomodulator |
US7695723B2 (en) * | 2002-12-31 | 2010-04-13 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
WO2017064571A1 (en) | 2015-09-25 | 2017-04-20 | Maxivax Sa | Vaccination with immuno-isolated cells producing an immunomodulator |
US20220403001A1 (en) | 2018-06-12 | 2022-12-22 | Obsidian Therapeutics, Inc. | Pde5 derived regulatory constructs and methods of use in immunotherapy |
WO2020123716A1 (en) | 2018-12-11 | 2020-06-18 | Obsidian Therapeutics, Inc. | Membrane bound il12 compositions and methods for tunable regulation |
EP3935159A1 (en) | 2019-03-08 | 2022-01-12 | Obsidian Therapeutics, Inc. | Human carbonic anhydrase 2 compositions and methods for tunable regulation |
US20220267398A1 (en) | 2019-06-12 | 2022-08-25 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
US20220259284A1 (en) | 2019-06-12 | 2022-08-18 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
WO2021040736A1 (en) | 2019-08-30 | 2021-03-04 | Obsidian Therapeutics, Inc. | Tandem cd19 car-based compositions and methods for immunotherapy |
US20220332780A1 (en) | 2019-09-10 | 2022-10-20 | Obsidian Therapeutics, Inc. | Ca2-il15 fusion proteins for tunable regulation |
-
1997
- 1997-10-15 WO PCT/US1997/018455 patent/WO1998016246A1/en not_active Application Discontinuation
- 1997-10-15 EP EP97910921A patent/EP0930892A1/en not_active Ceased
- 1997-10-15 AU AU48182/97A patent/AU4818297A/en not_active Abandoned
- 1997-10-15 CA CA002267977A patent/CA2267977A1/en not_active Abandoned
- 1997-10-15 JP JP10518504A patent/JP2001502331A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2267977A1 (en) | 1998-04-23 |
JP2001502331A (en) | 2001-02-20 |
EP0930892A1 (en) | 1999-07-28 |
WO1998016246A1 (en) | 1998-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4670897A (en) | Methods for producing low binding surfaces | |
AU3989297A (en) | Hyper-text document preparing apparatus | |
AU4781297A (en) | Vaccines | |
AU4818297A (en) | Cytokine enhanced immunotherapy for brain tumors | |
AU3427697A (en) | Securing-piece attaching apparatus | |
AU3497297A (en) | Roller-ski apparatus | |
AU5317398A (en) | Method for preparing cyclopropylamines | |
AU4704197A (en) | Adjustable reflector | |
AU1769497A (en) | Modified cytokines for therapeutic use | |
AU1733997A (en) | Blower-vacuum apparatus | |
AU2810497A (en) | Methods for inducing bone formation | |
AUPO204596A0 (en) | Block feeding means | |
AU1805897A (en) | An adjustable bed | |
AU3225097A (en) | Immunotherapy for autoimmune disease | |
AU696142B2 (en) | Infusion apparatus | |
AU1672397A (en) | Brain activators | |
AU2137097A (en) | Adjustable boot-binding mount for snowboard | |
EP0904287A3 (en) | Cytokine designated lerk-8 | |
AU4728597A (en) | Headrest | |
GB2312297B (en) | Stereo slide mount | |
AU4483597A (en) | Novel tumor proteins | |
AU2987097A (en) | De-wiring apparatus | |
AU4502797A (en) | Immunological therapy for cancer | |
AU4288897A (en) | Support apparatus | |
AU2924897A (en) | Tumor suppressor gene |